Dry Eye Treatment

Published on the European Journal of Ophthalmology, goes and compares eye-light® technologies with pharmaceutical treatments (i.e., eye drops)—proving yet again the superiority of light therapy, especially in the long run (after 6 months).

Here below the main findings:

1. Efficacy of Treatments: The study found that both the combined Intense Pulsed Light (IPL) and Low-Level Light Therapy (LLLT) and the hyaluronate sodium drops were effective in treating dry eye disease. However, the combined light therapy showed a statistically significant improvement over the drops.
    
2. Tear Breakup Time (TBUT): The TBUT increased significantly in both groups, but the increase was more pronounced in the light therapy group.
    
3. Schirmer Test: The Schirmer test results showed a significant increase in tear production in the light therapy group compared to the drop group.
    
4. Ocular Surface Disease Index (OSDI): The OSDI scores decreased significantly in both groups, indicating an improvement in symptoms. However, the decrease was more significant in the light therapy group.
    

The study showed statistically significant improvements in ocular surface disease index score (OSDI) and symptom assessment in dry eye (SANDE) scores with our device, which were not observed in artificial tear users. In other words, patients are seeing and reporting improvements in their dry eye symptoms. Findings like this are crucial to motivating patients to continue treatment.